In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2755-2759

  Tang, Hung Jen ^a   Ko, Wen Chien ^b   Chen, Chi Chung ^a   Chen, Po Lin ^b   Toh, Han Siong ^a   Weng, Tzu Chieh ^a   Yu, Wen Liang ^a   Chiang, Shyh Ren ^a   Chuang, Yin Ching ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; TIGECYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONITIS; PRIORITY JOURNAL; SALMONELLA; SURVIVAL RATE;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PERITONITIS; SALMONELLA; SALMONELLA INFECTIONS; SURVIVAL RATE;

EID: 79956324639     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01807-10     Document Type: Article

References (35)

1. Azoulay-Dupuis, E., et al. 2004. Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia. Antimicrob. Agents Chemother. 48:1105-1111.
2. Biedenbach, D. J., M. Toleman, T. R. Walsh, and R. N. Jones. 2006. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis. 54:13-21.
3. Chacon-Moreno, B. E., et al. 2009. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice. Antimicrob. Agents Chemother. 53:295-297.
4. Chang, H. R., I. R. Vladoianu, and J. C. Pechere. 1990. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim- sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J. Antimicrob. Chemother. 26:689-694.
5. Chiu, C. H., et al. 2002. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N. Engl. J. Med. 346:413-419.
6. Chiu, C. H., T. L. Wu, L. H. Su, J. W. Liu, and C. Chu. 2004. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg. Infect. Dis. 10:1674-1676.
7. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement. CLSI document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Easmon, C. S., J. P. Crane, and A. Blowers. 1986. Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. J. Antimicrob. Chemother. 18(Suppl. D):43-48.
10. Filho, L. S., J. L. Kuti, and D. P. Nicolau. 2007. Employing pharmacokinetic and pharmacodynamic principles to optimize antimicrobial treatment in the face of emerging resistance. Braz. J. Microbiol. 38:183-193.
11. Hohmann, E. L. 2001. Nontyphoidal salmonellosis. Clin. Infect. Dis. 32:263-269.
12. Ko, W. C., et al. 2005. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and cipro- floxacin-resistant Salmonella enterica serotype choleraesuis. Clin. Infect. Dis. 40:315-318.
13. Koomanachai, P., A. Kim, and D. P. Nicolau. 2009. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. J. Antimicrob. Chemother. 63:982-987.
14. Lee, H. Y., et al. 2009. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob. Agents Chemother. 53:2696-2699.
15. Liu, C. Y., Y. T. Huang, C. H. Liao, and P. R. Hsueh. 2008. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrob. Agents Chemother. 52:2677-2679.
16. Matsumoto, Y., et al. 2001. Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrob. Agents Chemother. 45:2450-2454.
17. Mead, P. S., et al. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
18. Meagher, A. K., P. G. Ambrose, T. H. Grasela, and E. J. Ellis-Grosse. 2005. Pharmacokinetic/pharmacodynamic profile for tigecycline - a new glycylcycline antimicrobial agent. Diagn. Microbiol. Infect. Dis. 52:165-171.
19. Menashe, O., E. Kaganskaya, T. Baasov, and S. Yaron. 2008. Aminoglycosides affect intracellular Salmonella enterica serovars Typhimurium and Virchow. Antimicrob. Agents Chemother. 52:920-926.
20. Ong, C. T., C. P. Babalola, C. H. Nightingale, and D. P. Nicolau. 2005. Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs). J. Antimicrob. Chemother. 56:498-501.
21. Patel, I. H., et al. 1981. Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents Chemother. 20:634-641.
22. Piercy, E. A., R. E. Bawdon, and P. A. Mackowiak. 1989. Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects. Antimicrob. Agents Chemother. 33:1645-1646.
23. Reagan-Shaw, S., M. Nihal, and N. Ahmad. 2008. Dose translation from animal to human studies revisited. FASEB J. 22:659-661. (Pubitemid 351348146)
24. Saliba, R., L. Paasch, and A. El Solh. 2009. Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol. Immunotoxicol. 31:583-588.
25. Salvatore, C. M., et al. 2009. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia. Antimicrob. Agents Chemother. 53:1546-1551.
26. Sauve, C., et al. 1996. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40: 2829-2834. (Pubitemid 26404353)
27. Su, L. H., C. H. Chiu, C. Chu, and J. T. Ou. 2004. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin. Infect. Dis. 39:546-551.
28. Su, L. H., et al. 2003. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype Anatum. Antimicrob. Agents Chemother. 47:563-567.
29. Su, L. H., et al. 2001. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol. Infect. 127:207-213.
30. Su, L. H., et al. 2005. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 55:846-852.
31. Threlfall, E. J. 2002. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev. 26:141-148.
32. van Ogtrop, M. L., et al. 2000. In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various Gram-positive and Gram-negative bacteria. Antimicrob. Agents Chemother. 44:943-949.
33. Vugia, D. J., et al. 2004. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin. Infect. Dis. 38(Suppl. 3):S149-S156.
34. Yan, J. J., et al. 2003. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. Emerg. Infect. Dis. 9:323-328.
35. Yang, Y. J., et al. 1998. High rates of antimicrobial resistance among clinical isolates of nontyphoidal Salmonella in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 17:880-883.